{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T13:54:14Z","timestamp":1772286854672,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaccas.2025.105069","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T04:49:37Z","timestamp":1762318177000},"page":"105069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Smoldering Myocarditis Unmasked by Pembrolizumab-Induced Myositis"],"prefix":"10.1016","volume":"30","author":[{"given":"Justin D.","family":"Mark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben K.A.","family":"Tapia-Orihuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry L.","family":"Charnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Muniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2025.105069_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013757","article-title":"Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment","volume":"9","author":"Palaskas","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jaccas.2025.105069_bib2","article-title":"Pembrolizumab-induced smoldering myocarditis in patients with triple-negative breast cancer","volume":"30","author":"Shaaban","year":"2025","journal-title":"Case Rep"},{"key":"10.1016\/j.jaccas.2025.105069_bib3","doi-asserted-by":"crossref","first-page":"5399073","DOI":"10.1155\/2024\/5399073","article-title":"Immunotherapy-induced overlap syndrome: myositis, myasthenia gravis, and myocarditis-A case series","volume":"2024","author":"Aggarwal","year":"2024","journal-title":"Case Rep Med"},{"issue":"3","key":"10.1016\/j.jaccas.2025.105069_bib4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10555-021-09976-0","article-title":"Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners","volume":"40","author":"Wojtukiewicz","year":"2021","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.jaccas.2025.105069_bib5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jaccao.2022.04.007","article-title":"Late-onset immunotherapy-induced myocarditis 2 years after checkpoint inhibitor initiation","volume":"4","author":"Nguyen","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"6","key":"10.1016\/j.jaccas.2025.105069_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12471-021-01655-7","article-title":"Immune checkpoint inhibitor-associated myocarditis: case reports and a review of the literature","volume":"30","author":"Osinga","year":"2022","journal-title":"Neth Heart J"},{"issue":"5","key":"10.1016\/j.jaccas.2025.105069_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaccao.2024.07.001","article-title":"Cardiac troponin I and T in ICI myocarditis screening, diagnosis, and prognosis","volume":"6","author":"Barac","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jaccas.2025.105069_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2024.10.080","article-title":"2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis: a report of the American College of Cardiology solution set oversight committee","volume":"85","author":"Drazner","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2025.105069_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41379-019-0363-0","article-title":"Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms","volume":"33","author":"Champion","year":"2020","journal-title":"Mod Pathol"},{"issue":"24","key":"10.1016\/j.jaccas.2025.105069_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMc1903064","article-title":"Alemtuzumab for immune-related myocarditis due to PD-1 therapy","volume":"380","author":"Esfahani","year":"2019","journal-title":"N Engl J Med"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925018492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925018492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:59:03Z","timestamp":1764766743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925018492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666084925018492"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105069","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smoldering Myocarditis Unmasked by Pembrolizumab-Induced Myositis","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"105069"}}